Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2011-08-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm200370yPMID 21751791
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efflux-Mediated Drug Resistance in Bacteria

  2012cited by this paper
• Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

  2011cited by this paper
• From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps.

  2010cited by this paper
• Efflux-Mediated Drug Resistance in Bacteria

  2009cited by this paper
• Desperately Seeking New Antibiotics

  2008cited by this paper
• From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.

  2008cited by this paper
• Inactivation of Efflux Pumps Abolishes Bacterial Biofilm Formation

  2008cited by this paper
• Bacterial efflux pump inhibitors from natural sources.

  2007cited by this paper
• Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

  2007cited by this paper
• Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.

  2007cited by this paper
• Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005

  2007cited by this paper
• The end of an era?

  2007cited by this paper
• Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors.

  2006cited by this paper
• Can efflux inhibitors really counter resistance

  2006cited by this paper
• Daptomycin: first in a new class of antibiotics for complicated skin and soft‐tissue infections

  2006cited by this paper
• High-Level Vancomycin-Resistant Staphylococcus aureus Isolates Associated with a Polymicrobial Biofilm

  2006cited by this paper
• Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.

  2006cited by this paper
• Synthesis of Omeprazole Analogues and Evaluation of These as Potential Inhibitors of the Multidrug Efflux Pump NorA of Staphylococcus aureus

  2006cited by this paper
• Antibacterial discovery and development—the failure of success?

  2006cited by this paper
• A quantitative structure-activity relationship study of herbicidal analogues of alpha-hydroxy-substituted 3-benzylidenepyrrolidene-2,4-diones.

  2006cited by this paper
• Prediction and classification of protein functions.

  2006cited by this paper
• Tigecycline: a glycylcycline antimicrobial agent.

  2006cited by this paper
• Anti-staphylococcal plant natural products.

  2004cited by this paper
• Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria.

  2004cited by this paper
• Molecular similarity of MDR inhibitors

  2004cited by this paper
• Molecular Basis of Bacterial Outer Membrane Permeability Revisited

  2003cited by this paper
• Electrosynthesis of 3-chloro-1,4-disubstituted-2(1H)- quinolinones and 3,3-dichloro-4-hydroxy-1,4-disubstituted- 3,4-dihydro-2(1H)-quinolinones, as well as a new convenient process to dioxindoles.

  2003cited by this paper
• Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.

  2003cited by this paper
• Oxazolidinone structure-activity relationships leading to linezolid.

  2003cited by this paper
• Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.

  2003cited by this paper
• Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus

  2003cited by this paper
• A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus.

  2003cited by this paper
• Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.

  2003cited by this paper
• The importance of efflux pumps in bacterial antibiotic resistance.

  2003cited by this paper
• Isoflavones as potentiators of antibacterial activity.

  2003cited by this paper
• Mystery of multidrug transporters: the answer can be simple

  2002cited by this paper
• The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus.

  2002cited by this paper
• Fluoroquinolone resistance among Gram-positive cocci.

  2002cited by this paper
• Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance.

  2001cited by this paper
• Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships.

  2001cited by this paper
• Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.

  2000cited by this paper
• Evidence for the Existence of a Multidrug Efflux Transporter Distinct from NorA in Staphylococcus aureus

  2000cited by this paper
• Resisting resistance: new chemical strategies for battling superbugs.

  2000cited by this paper
• Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors.

  2000cited by this paper
• Effects of NorA Inhibitors on In Vitro Antibacterial Activities and Postantibiotic Effects of Levofloxacin, Ciprofloxacin, and Norfloxacin in Genetically Related Strains ofStaphylococcus aureus

  1999cited by this paper
• Bacterial antibiotic efflux systems of medical importance

  1999cited by this paper
• The multidrug efflux protein NorM is a prototype of a new family of transporters

  1999cited by this paper
• Use of a Genetic Approach To Evaluate the Consequences of Inhibition of Efflux Pumps in Pseudomonas aeruginosa

  1999cited by this paper
• Synthesis of 2-Arylquinoline and 2-Aryl-4-quinolone Alkaloids via Diels-Alder Reaction of 1, 2, 3-Benzotriazine with Enamines

  1999cited by this paper
• The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.

  1998cited by this paper
• Bacterial enzymatic resistance: beta-lactamases and aminoglycoside-modifying enzymes.

  1998cited by this paper
• Major Facilitator Superfamily

  1998cited by this paper
• The ABC family of multidrug transporters in microorganisms.

  1998cited by this paper
• Bacterial enzymatic resistance: β-lactamases and aminoglycoside-modifying enzymes

  1998cited by this paper
• Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus

  1997cited by this paper
• Antibacterial efflux systems : Frontiers in antimicrobial resistance

  1997cited by this paper
• Antibacterial efflux systems.

  1997cited by this paper
• Antibacterial efflux systems.

  1997cited by this paper
• The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs

  1996cited by this paper
• Erythromycin resistance by ribosome modification

  1995cited by this paper
• Flavonoids. Part 45. A General and Efficient Synthesis of Hydroxyflavones and ‐chromones.

  1995cited by this paper
• Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport

  1994cited by this paper
• Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin.

  1993cited by this paper
• Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis.

  1992cited by this paper
• Antibody used to identify penicillin‐binding protein 2' in methicillin‐resistant strains of Staphylococcus aureus (MRSA)

  1987cited by this paper
• The crystal structure of beta-lactamase from Staphylococcus aureus at 0.5 nm resolution.

  1985cited by this paper
• Recherches sur les substances mesogenes—VIII

  1981cited by this paper
• Japonin, 1-methyl-2-phenyl-3,6-dimethoxy-chinolon-(4), ein neues alkaloid aus Orixa japonica

  1970cited by this paper

• NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives

  2025cites this paper
• A Mechanistic Framework for Repurposing FDA-Approved Drugs to Combat Antimicrobial Resistance: The Case of Staphylococcus aureus.

  2025cites this paper
• Addressing Data Point Homogeneity and Annotation Challenges to Enhance Data‐Driven Approaches: The S. aureus NorA Efflux Pump Case Study

  2025cites this paper
• Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to Acinetobacter baumannii

  2024cites this paper
• Domino Approach to Heterocycles-Based Unsymmetrical Triarylmethanes through Heteroannulation of 2-(2-Enynyl)-pyridines with Enaminones.

  2024cites this paper
• Quinoline as a Privileged Structure: A Recent Update on Synthesis and Biological Activities.

  2024cites this paper
• Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry.

  2024cites this paper
• Unraveling the ligand specificity and promiscuity of the Staphylococcus aureus NorA efflux pump: a computational study

  2024cites this paper
• Application of Quinoline Ring in Structural Modification of Natural Products

  2023cites this paper
• Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors

  2023cites this paper
• Antibacterial activity of paroxetine against Staphylococcus aureus and possible mechanisms of action.

  2023cites this paper
• Palladium Catalyzed Annulation of o-Iodo-Anilines with Propargyl Alcohols: Synthesis of Substituted Quinolines.

  2023cites this paper
• Antibacterial Activity of Quinoline‐Based Derivatives against Methicillin‐Resistant Staphylococcus aureus and Pseudomonas aeruginosa: Design, Synthesis, DFT and Molecular Dynamic Simulations

  2023cites this paper
• Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria.

  2022cites this paper
• New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.

  2022cites this paper
• Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity

  2022cites this paper
• Efflux pump and its inhibitors: Cause and cure for multidrug resistance

  2022cites this paper
• Phenolic Compound Ethyl 3,4-Dihydroxybenzoate Retards Drug Efflux and Potentiates Antibiotic Activity

  2022cites this paper
• Urea-Based Ligand as an Efflux Pump Inhibitor: Warhead to Counter Ciprofloxacin Resistance and Inhibit Collagen Adhesion by MRSA.

  2022cites this paper
• The crafty opponent: the defense systems of Staphylococcus aureus and response measures

  2022cites this paper
• Bacterial Drug Efflux Pump Inhibitors from Plants

  2022cites this paper
• Efflux Pump Mediated Antimicrobial Resistance by Staphylococci in Health-Related Environments: Challenges and the Quest for Inhibition

  2021cites this paper
• Development of an Antibiotic Resistance Breaker to Resensitize Drug-Resistant Staphylococcus aureus: In Silico and In Vitro Approach

  2021cites this paper
• Microbial Efflux Pump Inhibitors: A Journey around Quinoline and Indole Derivatives

  2021cites this paper
• Focused review on dual inhibition of quorum sensing and efflux pumps: A potential way to combat multi drug resistant Staphylococcus aureus infections.

  2021cites this paper
• Fluorine-containing 2,3-diaryl quinolines as potent inhibitors of methicillin and vancomycin-resistant Staphylococcus aureus: Synthesis, antibacterial activity and molecular docking studies

  2021cites this paper
• Practical iridium-catalyzed direct α-arylation of N-heteroarenes with (hetero)arylboronic acids by H2O-mediated H2 evolution

  2021cites this paper
• Chemical synthesis, molecular docking and MepA efflux pump inhibitory effect by 1,8-naphthyridines sulfonamides.

  2021cites this paper
• From Quinoline to Quinazoline‐Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search

  2021cites this paper
• Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.

  2021cites this paper
• Prospects and Obstacles for Clinical Use of the Inhibitors of Mycobacterium tuberculosis Efflux Pumps

  2021cites this paper
• Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors

  2020cites this paper
• An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors.

  2020cites this paper
• Modulation of the drug resistance by Platonia insignis Mart. extract, ethyl acetate fraction and Morelloflavone/Volkensiflavone (biflavonoids) in Staphylococcus aureus strains overexpressing efflux pump genes.

  2020cites this paper
• Visible-light-induced photoxidation-Povarov cascade reaction: synthesis of 2-arylquinoline through alcohol and N-benzylanilines under mild conditions via Ag/g-C3N4 nanometric semiconductor catalyst.

  2020cites this paper
• C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors

  2020cites this paper
• Modulation of the resistance to norfloxacin in Staphylococcus aureus by Bauhinia forficata link

  2019cites this paper
• Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach

  2019cites this paper
• Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

  2019cites this paper
• Small AntiMicrobial Peptide with In Vivo Activity Against Sepsis

  2019cites this paper
• Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells

  2019cites this paper
• Efflux pump inhibitors for bacterial pathogens: From bench to bedside

  2019cites this paper
• C3‐Functionalized Chromones Synthesis by Tandem C−H Elaboration and Chromone Annulation of Enaminones

  2019cites this paper
• Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.

  2019cites this paper
• Tunable synthesis of quinolinone-fused isoquinolines through sequential one-pot nucleophilic addition and palladium-catalyzed intramolecular C-H alkenylation.

  2019cites this paper
• Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by Phyllanthin.

  2019cites this paper
• para-TsOH-Promoted Cascade Reaction ofortho-Propynol Phenyl Azides for the Synthesis of 4-Methoxy Quinolines and Propargyl Methyl Ethers: Insight on Mechanism of Propargylic Alcohols

  2019cites this paper
• Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position.

  2018cites this paper
• Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids.

  2018cites this paper
• Overcoming problems of poor drug penetration into bacteria: challenges and strategies for medicinal chemists

  2018cites this paper
• MeOTf-induced annulation of arylisocyanates and arylalkynes leading to 4-methoxyl-2,3-diarylquinolines

  2018cites this paper
• 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.

  2018cites this paper
• 4-Quinolone derivatives and their activities against Gram positive pathogens.

  2018cites this paper
• Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo.

  2017cites this paper
• Amphiphilic Cargo‐Loaded Nanocarrier Enhances Antibiotic Uptake and Perturbs Efflux: Effective Synergy for Mitigation of Methicillin‐Resistant Staphylococcus aureus

  2017cites this paper
• Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli

  2017cites this paper
• The Halogen Bond as a Structure Director

  2017cites this paper
• Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.

  2017cites this paper
• Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.

  2017cites this paper
• Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation

  2017cites this paper
• (5-Chloroquinolin-8-yl)-2-fluorobenzoate. The Halogen Bond as a Structure Director

  2017cites this paper
• AgNO3-catalyzed direct C–H arylation of quinolines by oxidative decarboxylation of aromatic carboxylic acids

  2017cites this paper
• Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3‐Phenyl‐1,4‐benzothiazine Analogues

  2017cites this paper
• Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors.

  2017cites this paper
• Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms.

  2017cites this paper
• Lewis Acid Promoted Oxonium Ion Driven Carboamination of Alkynes for the Synthesis of 4-Alkoxy Quinolines.

  2017cites this paper
• The "racemic approach" in the evaluation of the enantiomeric NorA efflux pump inhibition activity of 2-phenylquinoline derivatives.

  2016cites this paper
• Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting methicillin-resistant Staphylococcus aureus DNA.

  2016cites this paper
• C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors

  2016cites this paper
• Pd-Catalyzed Ligand-Free Synthesis of Arylated Heteroaromatics by Coupling of N-Heteroaromatic Bromides with Iodobenzene Diacetate, Iodosobenzene, or Diphenyliodonium Salts.

  2016cites this paper
• Current Advances in Developing Inhibitors of Bacterial Multidrug 
Efflux Pumps

  2016cites this paper
• Construction of 1,3-disubstituted 4-oxo-1,4-dihydroquinolines as a potential antibacterial agents

  2016cites this paper
• Visible-light-mediated reaction: synthesis of quinazolinones from 1,2-dihydroquinazoline 3-oxides

  2016cites this paper
• Antimicrobial Drug Efflux Pump Inhibitors

  2016cites this paper
• Indole Based Weapons to Fight Antibiotic Resistance: A Structure-Activity Relationship Study.

  2016cites this paper
• Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.

  2016cites this paper
• Identification of benzochromene derivatives as a highly specific NorA efflux pump inhibitor to mitigate the drug resistant strains of S. aureus

  2016cites this paper
• Imidazolidine-4-one derivatives in the search for novel chemosensitizers of Staphylococcus aureus MRSA: synthesis, biological evaluation and molecular modeling studies.

  2015cites this paper
• Potencial de compostos fenólicos como antimicrobianos e/ou moduladores da resistência em Staphylococcus aureus

  2015cites this paper
• In vitro and in vivo synergistic interaction of substituted chalcone derivatives with norfloxacin against methicillin resistant Staphylococcus aureus

  2015cites this paper
• Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium.

  2015cites this paper
• Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.

  2015cites this paper
• Novel synthetic bis-indolic derivatives with antistaphylococcal activity, including against MRSA and VISA strains.

  2015cites this paper
• Copper-catalyzed cascade addition route to 2,3,4-trisubstituted quinoline derivatives

  2015cites this paper
• Practical and Versatile Synthesis of Thioflavones from 2-Bromobenzoyl Chlorides

  2015cites this paper
• Antibiotic Adjuvants: Diverse Strategies for Controlling Drug-Resistant Pathogens

  2014cites this paper
• 1‐(1H‐Indol‐3‐yl)ethanamine Derivatives as Potent Staphylococcus aureus NorA Efflux Pump Inhibitors

  2014cites this paper
• Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin.

  2014cites this paper
• Flavonoids from Sophora moorcroftiana and their Synergistic Antibacterial Effects on MRSA

  2014cites this paper
• Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs

  2014cites this paper
• Studies of overcoming acquired resistance : molecular mechanisms and development of novel drugs

  2014cites this paper
• MODULAÇÃO DA RESISTÊNCIA A DROGAS POR ÓLEOS ESSENCIAIS EM LINHAGENS DE STAPHYLOCOCCUS AUREUS

  2014cites this paper
• First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.

  2014cites this paper
• Challenges and future prospects of antibiotic therapy: from peptides to phages utilization

  2014cites this paper
• Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.

  2013cites this paper
• Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics.

  2013cites this paper
• Synthesis of 2,4-unsubstituted quinoline-3-carboxylic acid ethyl esters from arylmethyl azides via a domino process.

  2013cites this paper
• Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

  2013cites this paper
• Inhibition of drug efflux pumps in Staphylococcus aureus: current status for potentiating existing

  2013cites this paper
• Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA.

  2013cites this paper